Global Personalized Cancer Medicine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

REPORT SUMMARY
TABLE OF CONTENTS

Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors customize treatment to individual patient needs. Personalized treatments may cause fewer side effects than standard options. Some people are already benefiting from this approach.

Personalized Cancer Medicine market report explains the definition, types, applications, major countries, and major players of the Personalized Cancer Medicine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

The report contains qualitative and quantitative analysis of the entire industry.

The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

By Player:
- Rосhе
- Меrсk
- Сеlgеnе
- Вауеr
- Nоvаrtіѕ
- Аmgеn
- Аѕtеllаѕ
- Јоhnѕоn & Јоhnѕоn
- Аѕtrаzеnеса
- Аbbоtt
By Type:
- Monoclonal Antibodies
- Personalized Cancer Vaccines
- Other
By End-User:
- Breast Cancer
- Lung Cancer
- Chronic Myeloid Leukaemia
- Bowel Cancer
- Other Cancer
By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- UK
- Spain
- France
- Italy
- Denmark
- Finland
- Norway
- Sweden
- Poland
- Russia
- Turkey
Asia-Pacific
- China
- Japan
- India
- South Korea
- Pakistan
- Bangladesh
- Indonesia
- Thailand
- Singapore
- Malaysia
- Philippines
- Vietnam
- Others
South America
- Brazil
- Colombia
- Chile
- Argentina
- Venezuela
- Peru
- Puerto Rico
- Ecuador
- Others
GCC
- Bahrain
- Kuwait
- Oman
- Qatar
- Saudi Arabia
- United Arab Emirates
Africa
- Nigeria
- South Africa
- Egypt
- Algeriat
- Others
Oceania
- Australia
- New Zealand
TABLE OF CONTENT
1. Global Personalized Cancer Medicine Executive Summary
- 1.1 Introduction
- 1.2 Market Panorama, 2022
2 Coronavirus Impact
- 2.1 Personalized Cancer Medicine Outlook to 2028- Original Forecasts
- 2.2 Personalized Cancer Medicine Outlook to 2028- COVID-19 Affected Forecasts
- 2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
- 3.1 Potential Market Drivers and Opportunities
- 3.2 New Challenges and Strategies
- 3.3 Short Term and Long Term Personalized Cancer Medicine Market Trends
4 Key Inferences
5 Market Overview
- 5.1 Current Market Scenario
- 5.2 Porter's Five Forces Analysis
6 Global Personalized Cancer Medicine Market- Recent Developments
- 6.1 Personalized Cancer Medicine Market News and Developments
- 6.2 Personalized Cancer Medicine Market Deals Landscape
7 Personalized Cancer Medicine Raw Materials and Cost Structure Analysis
- 7.1 Personalized Cancer Medicine Key Raw Materials
- 7.2 Personalized Cancer Medicine Price Trend of Key Raw Materials
- 7.3 Personalized Cancer Medicine Key Suppliers of Raw Materials
- 7.4 Personalized Cancer Medicine Market Concentration Rate of Raw Materials
- 7.5 Personalized Cancer Medicine Cost Structure Analysis
8 Global Personalized Cancer Medicine Import and Export Analysis (Top 10 Countries)
- 8.1 Global Personalized Cancer Medicine Import by Region (Top 10 Countries) (2017-2028)
- 8.2 Global Personalized Cancer Medicine Export by Region (Top 10 Countries) (2017-2028)
9 Global Personalized Cancer Medicine Market Outlook by Types and Applications to 2022
- 9.1 Global Personalized Cancer Medicine Consumption and Growth Rate by Type (2017-2022)
- 9.2 Global Personalized Cancer Medicine Consumption and Growth Rate by Application (2017-2022)
10 Region and Country-wise Personalized Cancer Medicine Market Analysis and Outlook till 2022
- 10.1 Global Personalized Cancer Medicine Consumption (2017-2022)
- 10.2 North America Consumption Analysis
- 10.3 Europe Consumption Analysis
- 10.4 APAC Consumption Analysis
- 10.5 South America Consumption Analysis
- 10.6 GCC Consumption Analysis
- 10.7 Africa Consumption Analysis
- 10.8 Oceania Consumption Analysis
11 Global Personalized Cancer Medicine Competitive Analysis
- 11.1 Rосhе
- 11.2 Меrсk
- 11.3 Сеlgеnе
- 11.4 Вауеr
- 11.5 Nоvаrtіѕ
- 11.6 Аmgеn
- 11.7 Аѕtеllаѕ
- 11.8 Јоhnѕоn & Јоhnѕоn
- 11.9 Аѕtrаzеnеса
- 11.10 Аbbоtt
12 Global Personalized Cancer Medicine Market Outlook by Types and Applications to 2028
- 12.1 Global Personalized Cancer Medicine Consumption Forecast and Growth Rate by Type (2022-2028)
- 12.2 Global Personalized Cancer Medicine Consumption Forecast and Growth Rate by Application (2022-2028)
13 Country-wise Personalized Cancer Medicine Market Analysis and Outlook to 2028
- 13.1 Global Personalized Cancer Medicine Consumption Forecast (2022-2028)
- 13.2 North America Consumption Analysis
- 13.3 Europe Consumption Analysis
- 13.4 APAC Consumption Analysis
- 13.5 South America Consumption Analysis
- 13.6 GCC Consumption Analysis
- 13.7 Africa Consumption Analysis
- 13.8 Oceania Consumption Analysis
14 Conclusions
The List of Tables and Figures
- Table Definition of Personalized Cancer Medicine
- Figure of Personalized Cancer Medicine Picture
- Table Global Personalized Cancer Medicine Import by Region (Top 10 Countries) (2017-2028)
- Table Global Personalized Cancer Medicine Export by Region (Top 10 Countries) (2017-2028)
- Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
- Figure Global Personalized Cancer Vaccines Consumption and Growth Rate (2017-2022)
- Figure Global Other Consumption and Growth Rate (2017-2022)
- Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
- Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
- Figure Global Chronic Myeloid Leukaemia Consumption and Growth Rate (2017-2022)
- Figure Global Bowel Cancer Consumption and Growth Rate (2017-2022)
- Figure Global Other Cancer Consumption and Growth Rate (2017-2022)
- Figure Global Personalized Cancer Medicine Consumption by Country (2017-2022)
- Table North America Personalized Cancer Medicine Consumption by Country (2017-2022)
- Figure United States Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Canada Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Mexico Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Table Europe Personalized Cancer Medicine Consumption by Country (2017-2022)
- Figure Germany Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure UK Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Spain Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Belgium Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure France Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Italy Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Denmark Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Finland Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Norway Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Sweden Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Poland Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Russia Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Turkey Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Table APAC Personalized Cancer Medicine Consumption by Country (2017-2022)
- Figure China Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Japan Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure India Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure South Korea Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Pakistan Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Bangladesh Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Indonesia Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Thailand Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Singapore Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Malaysia Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Philippines Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Vietnam Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Table South America Personalized Cancer Medicine Consumption by Country (2017-2022)
- Figure Brazil Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Colombia Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Chile Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Argentina Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Venezuela Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Peru Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Puerto Rico Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Ecuador Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Table GCC Personalized Cancer Medicine Consumption by Country (2017-2022)
- Figure Bahrain Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Kuwait Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Oman Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Qatar Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Saudi Arabia Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure United Arab Emirates Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Table Africa Personalized Cancer Medicine Consumption by Country (2017-2022)
- Figure Nigeria Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure South Africa Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Egypt Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure Algeria Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Table Oceania Personalized Cancer Medicine Consumption by Country (2017-2022)
- Figure Australia Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Figure New Zealand Personalized Cancer Medicine Consumption and Growth Rate (2017-2022)
- Table Rосhе Company Details
- Table Rосhе Personalized Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Rосhе Personalized Cancer Medicine Main Business and Markets Served
- Table Rосhе Personalized Cancer Medicine Product Portfolio
- Table Меrсk Company Details
- Table Меrсk Personalized Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Меrсk Personalized Cancer Medicine Main Business and Markets Served
- Table Меrсk Personalized Cancer Medicine Product Portfolio
- Table Сеlgеnе Company Details
- Table Сеlgеnе Personalized Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Сеlgеnе Personalized Cancer Medicine Main Business and Markets Served
- Table Сеlgеnе Personalized Cancer Medicine Product Portfolio
- Table Вауеr Company Details
- Table Вауеr Personalized Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Вауеr Personalized Cancer Medicine Main Business and Markets Served
- Table Вауеr Personalized Cancer Medicine Product Portfolio
- Table Nоvаrtіѕ Company Details
- Table Nоvаrtіѕ Personalized Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Nоvаrtіѕ Personalized Cancer Medicine Main Business and Markets Served
- Table Nоvаrtіѕ Personalized Cancer Medicine Product Portfolio
- Table Аmgеn Company Details
- Table Аmgеn Personalized Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Аmgеn Personalized Cancer Medicine Main Business and Markets Served
- Table Аmgеn Personalized Cancer Medicine Product Portfolio
- Table Аѕtеllаѕ Company Details
- Table Аѕtеllаѕ Personalized Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Аѕtеllаѕ Personalized Cancer Medicine Main Business and Markets Served
- Table Аѕtеllаѕ Personalized Cancer Medicine Product Portfolio
- Table Јоhnѕоn & Јоhnѕоn Company Details
- Table Јоhnѕоn & Јоhnѕоn Personalized Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Јоhnѕоn & Јоhnѕоn Personalized Cancer Medicine Main Business and Markets Served
- Table Јоhnѕоn & Јоhnѕоn Personalized Cancer Medicine Product Portfolio
- Table Аѕtrаzеnеса Company Details
- Table Аѕtrаzеnеса Personalized Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Аѕtrаzеnеса Personalized Cancer Medicine Main Business and Markets Served
- Table Аѕtrаzеnеса Personalized Cancer Medicine Product Portfolio
- Table Аbbоtt Company Details
- Table Аbbоtt Personalized Cancer Medicine Sales, Price, Value and Gross Profit (2017-2022)
- Table Аbbоtt Personalized Cancer Medicine Main Business and Markets Served
- Table Аbbоtt Personalized Cancer Medicine Product Portfolio
- Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Personalized Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Chronic Myeloid Leukaemia Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Bowel Cancer Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Other Cancer Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Personalized Cancer Medicine Consumption Forecast by Country (2022-2028)
- Table North America Personalized Cancer Medicine Consumption Forecast by Country (2022-2028)
- Figure United States Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Canada Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Mexico Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Table Europe Personalized Cancer Medicine Consumption Forecast by Country (2022-2028)
- Figure Germany Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure UK Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Spain Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Belgium Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure France Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Italy Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Denmark Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Finland Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Norway Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Sweden Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Poland Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Russia Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Turkey Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Table APAC Personalized Cancer Medicine Consumption Forecast by Country (2022-2028)
- Figure China Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Japan Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure India Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure South Korea Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Pakistan Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Bangladesh Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Indonesia Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Thailand Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Singapore Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Malaysia Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Philippines Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Vietnam Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Table South America Personalized Cancer Medicine Consumption Forecast by Country (2022-2028)
- Figure Brazil Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Colombia Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Chile Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Argentina Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Venezuela Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Peru Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Puerto Rico Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Ecuador Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Table GCC Personalized Cancer Medicine Consumption Forecast by Country (2022-2028)
- Figure Bahrain Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Kuwait Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Oman Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Qatar Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Saudi Arabia Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure United Arab Emirates Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Table Africa Personalized Cancer Medicine Consumption Forecast by Country (2022-2028)
- Figure Nigeria Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure South Africa Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Egypt Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure Algeria Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Table Oceania Personalized Cancer Medicine Consumption Forecast by Country (2022-2028)
- Figure Australia Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)
- Figure New Zealand Personalized Cancer Medicine Consumption Forecast and Growth Rate (2022-2028)

Personalized Cancer Medicine Market Report

Global Personalized Cancer Medicine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

1. Global Personalized Cancer Medicine Executive Summary

2 Coronavirus Impact

3 Strategic Analytics to Boost Productivity and Profitability

4 Key Inferences

5 Market Overview

6 Global Personalized Cancer Medicine Market- Recent Developments

7 Personalized Cancer Medicine Raw Materials and Cost Structure Analysis

8 Global Personalized Cancer Medicine Import and Export Analysis (Top 10 Countries)

9 Global Personalized Cancer Medicine Market Outlook by Types and Applications to 2022

10 Region and Country-wise Personalized Cancer Medicine Market Analysis and Outlook till 2022

11 Global Personalized Cancer Medicine Competitive Analysis

12 Global Personalized Cancer Medicine Market Outlook by Types and Applications to 2028

13 Country-wise Personalized Cancer Medicine Market Analysis and Outlook to 2028

14 Conclusions

The List of Tables and Figures

Report Version Choose

Our Customers

Beyond Consulting, Future is Feasible

Quick Link

CONTACT US